Editorial review
Educational content is reviewed for source quality, clinical boundaries, and readability. It is not medical advice; confirm care decisions with a licensed clinician.
Telehealth ketamine vs in-clinic treatment comes down to a tradeoff between cost and convenience on one side, and administration options and direct medical supervision on the other. Telehealth ketamine programs ship sublingual troches to your home after a video evaluation, typically running $150 to $400 a month. In-clinic treatment administers ketamine on site, as an IV infusion, intramuscular injection, or Spravato (esketamine) nasal spray, under a clinical team's direct supervision, usually costing $1,600 to $3,200 a month for IV infusions.
Spravato is the FDA-approved nasal spray form of esketamine, prescribed alongside an oral antidepressant for treatment-resistant depression under a Risk Evaluation and Mitigation Strategy (REMS) program that requires in-office monitoring. Five years ago, choosing ketamine therapy meant visiting a clinic. Today, telehealth ketamine programs have made treatment accessible to patients with no clinic nearby or a limited budget, but the two models differ in absorption, safety oversight, and price. This comparison breaks down each difference so you can match the right model to your medical history, budget, and support system.
Quick Answer
Telehealth ketamine programs use sublingual troches shipped to your home after a video evaluation, typically costing $150 to $400 a month, with sessions you administer yourself alongside a treatment companion. In-clinic treatment offers IV infusion, intramuscular injection, or Spravato nasal spray under direct medical supervision, with more consistent absorption and continuous monitoring, but at a higher cost, often $1,600 to $3,200 a month for IV infusions. Telehealth tends to suit patients without complex medical history who prioritize cost and convenience, while in-clinic care is generally the safer choice for patients with cardiovascular risk factors or severe treatment-resistant symptoms. Many patients start in-clinic and later transition to telehealth for maintenance.
For a closer look at how at-home programs work, see our guide to custom at-home sublingual ketamine for anxiety.
How Telehealth Ketamine Programs Work
Video consultation
A prescribing provider, typically a psychiatrist, nurse practitioner, or physician assistant, reviews your medical history, psychiatric history, current medications, and treatment goals.
Pharmacy shipment
If approved, a licensed compounding pharmacy ships sublingual ketamine troches or tablets to your home.
Self-administered session
You take the medication at home during a scheduled session. Most programs require a treatment companion to be present.
Remote supervision
Depending on the program, supervision may include a real-time video check-in, a phone call, or a post-session check-in.
Follow-up by video
Regular video appointments track your response and adjust the treatment plan.
How In-Clinic Ketamine Treatment Works
In-person evaluation
You visit a specialized ketamine clinic for an initial assessment with the clinical team.
On-site administration
Treatment is given at the clinic, most often as an IV infusion, intramuscular injection, or Spravato nasal spray.
Continuous monitoring
Staff track your vital signs throughout the session.
Supervised recovery
You stay at the clinic until you have recovered enough to leave, with transportation arranged in advance.
In-person follow-up
Maintenance sessions and follow-up appointments happen at the same facility.
The route of administration affects how much ketamine reaches your bloodstream and how quickly you feel its effects. IV infusion delivers the full dose directly into circulation, which is why clinics use it when a fast, predictable response matters. Sublingual troches are held in the mouth and absorbed through the tissue there, so a smaller and more variable share of the dose reaches your bloodstream, depending on factors like saliva production and how long the troche is held before swallowing. For more on how oral and sublingual forms differ, see our guide to oral vs sublingual ketamine.
Spravato's REMS program builds monitoring into every dose. According to the FDA, patients must be observed at a certified treatment center for at least two hours after each dose and cannot drive themselves home the same day. The National Institute of Mental Health continues to track research into treatment-resistant depression, the population most ketamine and esketamine programs are built to serve. Read more about how the two forms compare in our guide to ketamine vs esketamine.
Telehealth Advantages
- Lower monthly cost, typically $150 to $400
- Treatment happens at home, without travel or time off work
- Good option for patients in areas with no nearby ketamine clinic
- Flexible scheduling around video appointments
Telehealth Considerations
- Lower and more variable absorption than IV or IM administration
- No on-site clinical staff if a reaction occurs during the session
- Requires a treatment companion to be present
- Not recommended for patients with cardiovascular risk factors or severe treatment-resistant symptoms
In-Clinic Advantages
- Direct medical supervision and continuous vital sign monitoring
- More consistent, predictable dosing through IV or IM administration
- Clinical staff on hand to manage an adverse reaction immediately
- Often preferred for patients with complex medical history or severe symptoms
In-Clinic Considerations
- Higher monthly cost, often $1,600 to $3,200 for IV infusions
- Requires travel to a clinic and time for supervised recovery
- Scheduling is tied to clinic hours and appointment availability
- Transportation must be arranged since patients cannot drive themselves home
Important
Ketamine can raise blood pressure and heart rate during a session. Patients with cardiovascular risk factors, a history of psychosis, or severe treatment-resistant symptoms should discuss whether in-clinic supervision is more appropriate with their prescribing provider before choosing a telehealth program. See our guide to ketamine side effects and safety for more on what monitoring involves.
Cost is often the deciding factor, but price alone does not capture what you are paying for. Before enrolling in either model, use this checklist to compare programs on more than monthly cost.
Questions to Ask Before Choosing a Program
- Ask what credentials the prescribing provider holds and whether they will be involved in ongoing care
- Ask what happens if you have an adverse reaction during a telehealth session
- Ask whether a treatment companion is required and what their role is
- Ask how the program handles dose adjustments and follow-up scheduling
- Ask what the total monthly cost includes, such as consultations, medication, and follow-up visits
- Ask whether the program coordinates with your existing prescriber or therapist
Key Takeaway
Neither model is universally safer or more effective. The right choice depends on your medical history, symptom severity, budget, and whether you have a support system in place for a self-administered session.
Telehealth ketamine tends to fit patients who do not have complex cardiovascular or psychiatric history, prioritize cost and convenience, and have a reliable treatment companion available for each session. In-clinic treatment is generally the safer choice for patients with cardiovascular risk factors, a history of psychosis, or severe treatment-resistant depression that has not responded to oral troches. It also fits anyone who wants continuous clinical monitoring during the highest-risk minutes of a session, right after dosing.
Before starting either model, ask your provider about continuity of care between visits; our guide on questions to ask a ketamine provider about continuity of care covers what to bring up at that first appointment. Many patients begin in-clinic to establish a stable response, then move to telehealth troches for lower-cost maintenance dosing once their treatment plan is set. See our maintenance treatment guide for how that transition typically works.
Read More Treatment Comparisons
Compare more ketamine treatment approaches to find the option that fits your medical history and budget.
Frequently Asked Questions
Yes. Many patients start with in-clinic infusions to establish a stable response under direct supervision, then move to telehealth troches for lower-cost maintenance dosing once their treatment plan is set. Talk to your prescribing provider before switching models so your dose and monitoring plan can be adjusted.
Effectiveness depends on the individual and the condition being treated. Sublingual troches are absorbed differently than IV infusion, so some patients need a different dose or frequency to reach a similar effect. Discuss your dosing history with your provider if you switch models.
Patients with cardiovascular risk factors, a history of psychosis, or severe treatment-resistant symptoms are generally better suited to in-clinic care, where clinical staff can monitor vital signs and respond immediately to any reaction.
Spravato (esketamine) is an FDA-approved nasal spray used alongside an oral antidepressant for treatment-resistant depression, administered under a REMS monitoring program. IV infusion and intramuscular injection use racemic ketamine and are typically prescribed off-label by ketamine clinics. See our guide to ketamine vs esketamine for a full comparison.
Telehealth sessions and in-clinic sessions both typically run about one to two hours including administration and observation time. See our guide to how long a ketamine session lasts for a breakdown by administration route.
Verdict
In-clinic treatment provides superior medical supervision, higher bioavailability routes (IV and IM), and a controlled therapeutic environment, making it the preferred choice for patients with complex medical needs or severe symptoms. Telehealth programs dramatically expand access through lower costs, geographic reach, and scheduling flexibility, making ketamine therapy realistic for millions of patients who would otherwise go untreated. Both are legitimate treatment pathways when delivered by qualified providers with proper screening protocols.
Share
Related Reading
Need help or want to reach readers?
Have a correction, provider question, or advertising inquiry? Reach the editorial team.